                              Sequence Listing

<110> GENENTECH, INC. and F. HOFFMANN-LA ROCHE AG, et al.

<120> ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF 
      OVARIAN CANCER

<130> P4411R1-WO

<141> 2011-02-22

<150> US 61/439,819
<151> 2011-02-04

<150> US 61/360,059
<151> 2010-06-30

<150> US 61/351,231
<151> 2010-06-03

<150> US 61/307,095
<151> 2010-02-23

<160> 2

<210> 1
<211> 123
<212> PRT
<213> Artificial sequence

<220>
<223> Sequence is Synthesized

<400> 1
 Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly
   1               5                  10                  15

 Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Phe Thr
                  20                  25                  30

 Asn Tyr Gly Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
                  35                  40                  45

 Glu Trp Val Gly Trp Ile Asn Thr Tyr Thr Gly Glu Pro Thr Tyr
                  50                  55                  60

 Ala Ala Asp Phe Lys Arg Arg Phe Thr Phe Ser Leu Asp Thr Ser
                  65                  70                  75

 Lys Ser Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp
                  80                  85                  90

 Thr Ala Val Tyr Tyr Cys Ala Lys Tyr Pro His Tyr Tyr Gly Ser
                  95                 100                 105

 Ser His Trp Tyr Phe Asp Val Trp Gly Gln Gly Thr Leu Val Thr
                 110                 115                 120

 Val Ser Ser
            

<210> 2
<211> 108
<212> PRT
<213> Artificial sequence

<220>
<223> Sequence is Synthesized

<400> 2
 Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val
   1               5                  10                  15

 Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Gln Asp Ile Ser
                  20                  25                  30

 Asn Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys
                  35                  40                  45

 Val Leu Ile Tyr Phe Thr Ser Ser Leu His Ser Gly Val Pro Ser
                  50                  55                  60

 Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile
                  65                  70                  75

 Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln
                  80                  85                  90

 Tyr Ser Thr Val Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu
                  95                 100                 105

 Ile Lys Arg
            

